首页 | 本学科首页   官方微博 | 高级检索  
检索        


Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?
Authors:Tibor Bakács  Jitendra N Mehrishi
Institution:1.Department of Probability, Alfred Rényi Institute of Mathematics, Hungarian Academy of Sciences,Budapest,Hungary;2.University of Cambridge,Cambridge,UK;3.The Cambridge Blood Cell, Stem Cells, Spermatozoa and Opioid Research Initiatives,Impington,UK
Abstract:

Background  

Most individuals who died of trauma were found to harbour microscopic primary cancers at autopsies. Surgical excision of the primary tumour, unfortunately, seems to disturb tumour dormancy in over half of all metastatic relapses.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号